Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
4.520
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $196.29 million as of April 26, 2024. Its market cap has decreased by -6.22% in one year.
Market Cap
196.29M
Enterprise Value
172.31M
1-Year Change
-6.22%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $196.29M, an increase of 42.44%. That is a compound annual growth rate of 3.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 196.30M | -0.86% |
Apr 24, 2024 | 198.00M | -0.45% |
Apr 23, 2024 | 198.90M | 0.20% |
Apr 22, 2024 | 198.50M | 1.12% |
Apr 19, 2024 | 196.30M | 0.46% |
Apr 18, 2024 | 195.40M | -3.03% |
Apr 17, 2024 | 201.50M | -2.70% |
Apr 16, 2024 | 207.10M | -0.34% |
Apr 15, 2024 | 207.80M | -0.29% |
Apr 12, 2024 | 208.40M | -2.84% |
Apr 11, 2024 | 214.50M | 0.37% |
Apr 10, 2024 | 213.70M | 4.04% |
Apr 9, 2024 | 205.40M | -4.24% |
Apr 8, 2024 | 214.50M | 2.48% |
Apr 5, 2024 | 209.30M | -1.83% |
Apr 4, 2024 | 213.20M | -2.38% |
Apr 3, 2024 | 218.40M | -1.67% |
Apr 2, 2024 | 222.10M | -0.89% |
Apr 1, 2024 | 224.10M | 6.66% |
Mar 28, 2024 | 210.10M | -2.32% |
Mar 27, 2024 | 215.10M | 3.81% |
Mar 26, 2024 | 207.20M | 1.42% |
Mar 25, 2024 | 204.30M | -2.06% |
Mar 22, 2024 | 208.60M | -1.37% |
Mar 21, 2024 | 211.50M | -3.34% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Telomir Pharmaceuticals | 203.27M |
Actinium Pharmaceuticals | 201.95M |
Lifecore Biomedical | 201.46M |
Innate Pharma | 198.87M |
Annovis Bio | 198.31M |
Profound Medical | 196.16M |
X4 Pharmaceuticals | 195.65M |
AEON Biopharma | 193.27M |